anakinra

pharmaceutical drug, interleukin 1 receptor antagonist
rdfs:label
"anakinra"@en
skos:altLabel
"Antril"@en
"ICIL-1RA"@en
"IL-1RN"@en
"IL-1ra"@en
"IL1 inhibitor"@en
"IRAP"@en
"interleukin-1 receptor antagonist protein precursor"@en
schema:description
"pharmaceutical drug, interleukin 1 receptor antagonist"@en
schema:dateModified "2026-11-04T08:54:27+00:00"^^xsd:dateTime
schema:version 2564626203
wikibase:identifiers 24
wikibase:sitelinks 22
wikibase:statements 45
p:P10245 wd:statement/Q415411-6b30ae2f-4026-cde4-1001-1965ca3dedf9
p:P10283 wd:statement/Q415411-7CBE7723-F34C-489A-BD6B-E4871E38ABF6
p:P11089 wd:statement/Q415411-01F1EFD6-B9FB-4B1E-8489-840D475AE5EB
p:P11143 wd:statement/Q415411-825BFA65-23E5-4E4B-9A59-07842AB95112
p:P1552 wd:statement/Q415411-50C1DE7D-916A-4C2A-80AF-95DD486F5810
p:P1748 wd:statement/Q415411-42F5021B-35AC-44A5-8157-0D0F20A8B767
p:P2017 wd:statement/Q415411-4C35467D-751A-4E3F-83CB-DA2BE29DCAE5
p:P2067 wd:statement/Q415411-4962F7A9-145B-4C31-A1FC-B2F6EBC6E97D
p:P2115 wd:statement/Q415411-C6850F3F-26B0-4DF9-90A0-23481EDBB9C8
p:P2175 wd:statement/Q415411-2A59E238-E2E1-4EB1-8110-D60F9157DCEF
wd:statement/Q415411-B15C5FB0-CCFD-4A45-8069-0A107AD112C1
wd:statement/Q415411-F42C1059-5E2C-448D-9467-2228970B8678
p:P231 wd:statement/Q415411-9A030C75-9F38-4D1E-8865-42C6D82E1095
p:P233 wd:statement/Q415411-9DAA692F-7105-426B-BF06-9DE96E5EA88F
p:P234 wd:statement/Q415411-F3961156-6B05-4AD4-B23A-6B69A371E5AC
p:P235 wd:statement/Q415411-69C8D080-D776-431E-9813-2DE1AA41B8FC
p:P267 wd:statement/Q415411-f7a766a8-4306-e467-63c7-9da433645599
p:P274 wd:statement/Q415411-d8e4f91c-4b2b-804d-2bf0-c719b022d976
p:P279 wd:statement/Q415411-34B159F2-304D-46ED-99CA-A7487DEEFCB1
p:P2868 wd:statement/Q415411-9A4B8C0E-7EFC-4C8D-9061-C6B4D45CD69C
p:P2877 wd:statement/Q415411-C360A3BE-D492-45E2-9795-0B0110BA1F9D
p:P31 wd:statement/Q415411-3B81048F-9D0D-46A4-A108-3FF70DE1BD80
p:P3345 wd:statement/Q415411-B223871E-C19A-494B-AB75-4036C94C862D
p:P3489 wd:statement/Q415411-3C3B5251-89CD-484D-BB15-3EB75CBB2C79
wd:statement/Q415411-926E7C5A-88EC-4201-8549-768B8A5E436C
p:P366 wd:statement/Q415411-CB1D260A-D338-407D-A902-D4D4B0571CE2
p:P3780 wd:statement/Q415411-AEC4B3FD-77BD-4B80-8E48-5BD140F9CAE9
p:P4235 wd:statement/Q415411-A2F3F5CD-6AEB-418D-903C-70281225156D
p:P4250 wd:statement/Q415411-04C5DCAE-1097-4819-8297-8EF3FAF86866
p:P4527 wd:statement/Q415411-6FAD5404-18DB-4913-830B-7CB309C2BFE0
p:P5076 wd:statement/Q415411-C81E7967-2432-47F4-9973-3B5DA6CCEBB8
p:P527 wd:statement/Q415411-B642AF02-05A8-4A23-9C07-397B1DADEB7A
p:P592 wd:statement/Q415411-C414F99B-077D-4F5B-B011-9EBBE0718BE9
p:P595 wd:statement/Q415411-2f10d6c4-40da-0911-cb35-7b9807001f84
p:P6366 wd:statement/Q415411-1BE24F15-F66F-4824-B583-1E3AAA26E556
p:P646 wd:statement/Q415411-455DE059-8E05-4DA8-8639-9AD1EED7192F
p:P652 wd:statement/Q415411-4AB954C4-6830-4182-8ECE-AA38B0A86E3A
p:P662 wd:statement/Q415411-DAD54559-B852-4849-A650-762F175A32A1
wd:statement/Q415411-e35aa53b-41f5-2ef6-28b0-4c815c130234
p:P665 wd:statement/Q415411-58E7419A-4E5A-44A5-BF8E-6C711CB6916A
p:P715 wd:statement/Q415411-A8FA7F2F-1FC7-4D40-A9BC-CCB997946D94
p:P769 wd:statement/Q415411-AE1D5A07-F1C6-4F25-9879-16E452DA76CB
p:P7830 wd:statement/Q415411-5266E22A-245A-452E-BC57-B9A3FE666950
p:P8026 wd:statement/Q415411-F19CB7CA-ED78-4984-85AC-072D9A1F896E
p:P8224 wd:statement/Q415411-562DEADF-6E33-40DC-B0EC-B4181F808D64
p:direct-normalized/P2115 <http://purl.bioontology.org/ontology/NDFRT/N0000148718>
p:direct-normalized/P4527 <http://data.parliament.uk/terms/434862>
p:direct-normalized/P592 <http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL1201570>
p:direct-normalized/P6366 <https://makg.org/entity/2781228260>
p:direct-normalized/P662 <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139595263>
<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90470007>
p:direct-normalized/P665 <http://www.kegg.jp/entry/D02934>
wdt:P10245 "a602001"
wdt:P10283 "C2781228260"
wdt:P11089 "170931737"
wdt:P11143 "Anakinra"
wdt:P1552 biopharmaceutical
wdt:P1748 "C38717"
wdt:P2017 "C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\OCOC(=O)C(C)(C)C)c3csc(=N)[nH]3)C2SC1"
wdt:P2067 509.103890076^^xsd:decimal
wdt:P2115 "N0000148718"
wdt:P2175 systemic-onset juvenile idiopathic arthritis
rheumatoid arthritis
pericarditis
wdt:P231 "143090-92-0"
wdt:P233 "C=CC1=C(C(=O)O)N2C(=O)C(NC(=O)C(=NOCOC(=O)C(C)(C)C)c3csc(=N)[nH]3)C2SC1"
wdt:P234 "InChI=1S/C20H23N5O7S2/c1-5-9-6-33-16-12(15(27)25(16)13(9)17(28)29)23-14(26)11(10-7-34-19(21)22-10)24-32-8-31-18(30)20(2,3)4/h5,7,12,16H,1,6,8H2,2-4H3,(H2,21,22)(H,23,26)(H,28,29)/b24-11-/t12-,16?/m1/s1"
wdt:P235 "HMLGSIZOMSVISS-ONJSNURVSA-N"
wdt:P267 "L04AC03"
wdt:P274 "C₂₀H₂₃N₅O₇S₂"
wdt:P279 7-[[2-(2-Amino-1,3-thiazol-4-yl)-2-(2,2-dimethylpropanoyloxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
wdt:P2868 enzyme inhibitor
wdt:P2877 "30295507"
wdt:P31 type of chemical entity
wdt:P3345 "72435"
wdt:P3489 US pregnancy category B
Australian pregnancy category B1
wdt:P366 medication
wdt:P3780 Kineret
wdt:P4235 "anakinra"
wdt:P4250 0.1^^xsd:decimal
wdt:P4527 "434862"
wdt:P5076 "RD-01-04926"
wdt:P527 carbon
wdt:P592 "CHEMBL1201570"
wdt:P595 "6972"
wdt:P6366 "2781228260"
wdt:P646 "/m/05_c6l"
wdt:P652 "9013DUQ28K"
wdt:P662 "139595263"
"90470007"
wdt:P665 "D02934"
wdt:P715 "DB00026"
wdt:P769 golimumab
wdt:P7830 "Anakinra"
wdt:P8026 LiverTox toxicity likelihood category C
wdt:P8224 <http://commons.wikimedia.org/wiki/Special:FilePath/Anakinra.png>
Download as:
TurtleJSON-LDRDF/XML
data from SPARQL profile: Wikidata